ACTONEL DR
Identification of Actonel Dr
| No description |
Google image searchProduct monograph
Active ingredient
risedronate sodium (risedronate sodium hemipentahydrate), 35 MG
DIN: 02370417
Dosage form(s): TABLET (DELAYED-RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 04-NOV-2022
ATC:
- M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
- M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
- M05BA — Bisphosphonates (ATC, ATC/DDD)
- M05BA07 — RISEDRONIC ACID (ATC/DDD)
Reference brand drug: Actonel
